Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2005 by Julius-Maximilians University.
Recruitment status was  Recruiting
Information provided by:
Julius-Maximilians University Identifier:
First received: April 19, 2005
Last updated: July 27, 2006
Last verified: June 2005
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given